Noble Biomaterials
A global leader in antimicrobial and conductivity solutions for soft surface applications. Home of Ionic+ & Circuitex.
A global leader in antimicrobial and conductivity solutions for soft surface applications. Home of Ionic+ & Circuitex.
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications, home of Ionic+ & Circuitex. Established in 1997, the company specializes in silver-based advanced material technologies catered to mission-critical applications in performance apparel, healthcare, industrial, and emerging wearable tech markets.
Noble's flagship brands, Ionic+ (X-STATIC, XT2) and Circuitex, are leveraged by over 250 world-class licensees to offer odor elimination, infection prevention/management, physiological monitoring, and conductive protection benefits. Notably, their technologies are integrated into products by renowned brands such as Lululemon, Giro, the US Military, NASA, 3M, and others.
With its headquarters in the United States, Noble Biomaterials received a $25.00K grant investment on 23 June 2020, with the investment coming from Ben Franklin Technology Partners of Northeastern Pennsylvania.
Noble Biomaterials operates in the biotechnology, healthcare, and manufacturing industries, emphasizing its commitment to delivering innovative solutions in these sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $25.00K | 1 |
|
23 Jun 2020 |
| Series C | Unknown | 1 |
|
01 Jul 2013 |
| Series B | $8.00M | 3 |
|
10 Feb 2012 |
No recent news or press coverage available for Noble Biomaterials.
We care about your data, and we'd love to use cookies make your experience better.
